CDC25A is also constitutively expressed downstream of oncogenic tyrosine kinases, including NPM-ALK and BCR-ABL [21], as well as JAK2 V617F in myeloproliferative neoplasms [22]. The gene discussed is JAK2; the disease is myeloproliferative disorder.